Following a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January.
In an interview, outgoing FDA commissioner Robert Califf was wary of the Trump administration but unapologetic about ...
The FDA granted Aduhelm an accelerated approval, meaning that Biogen has to carry out a post-marketing trial to confirm that it is effective, but critics say results from that will be years away.